Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: Implications for exfoliative toxin-mediated skin blistering

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 2921-2937

  Simpson, Cory L ^a   Kojima, Shin Ichiro ^a,b   Cooper Whitehair, Victoria ^a   Getsios, Spiro ^a   Green, Kathleen J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b GAKUSHUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN 1; DESMOSOMAL CADHERIN; PLAKOGLOBIN;

ARTICLE; BLISTER; CELL ADHESION; GENE TARGETING; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCAL SCALDED SKIN SYNDROME;

EID: 78649515383     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100397     Document Type: Article

References (86)

1. Green KJ, Simpson CL: Desmosomes: new perspectives on a classic. J Invest Dermatol 2007, 127:2499-2515
2. Dusek RL, Godsel LM, Green KJ: Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion. J Dermatol Sci 2007, 45:7-21
3. Cheng X, Koch PJ: In vivo function of desmosomes. J Dermatol 2004, 31:171-187
4. Lai-Cheong JE, Arita K, McGrath JA: Genetic diseases of junctions. J Invest Dermatol 2007, 127:2713-2725
5. Kottke MD, Delva E, Kowalczyk AP: The desmosome: cell science lessons from human diseases. J Cell Sci 2006, 119:797-806
6. Stanley JR, Amagai M: Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006, 355: 1800-1810
7. Rickman L, Simrak D, Stevens HP, Hunt DM, King IA, Bryant SP, Eady RA, Leigh IM, Arnemann J, Magee AI, Kelsell DP, Buxton RS: Nterminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet 1999, 8:971-976
8. Hunt DM, Rickman L, Whittock NV, Eady RA, Simrak D, Dopping-Hepenstal PJ, Stevens HP, Armstrong DK, Hennies HC, Kuster W, Hughes AE, Arnemann J, Leigh IM, McGrath JA, Kelsell DP, Buxton RS: Spectrum of dominant mutations in the desmosomal cadherin desmoglein 1, causing the skin disease striate palmoplantar keratoderma. Eur J Hum Genet 2001, 9:197-203
9. Wan H, Dopping-Hepenstal PJ, Gratian MJ, Stone MG, Zhu G, Purkis PE, South AP, Keane F, Armstrong DK, Buxton RS, McGrath JA, Eady RA: Striate palmoplantar keratoderma arising from desmoplakin and desmoglein 1 mutations is associated with contrasting perturbations of desmosomes and the keratin filament network. Br J Dermatol 2004, 150:878-891 (Pubitemid 38903519)
10. Payne AS, Hanakawa Y, Amagai M, Stanley JR: Desmosomes and disease: pemphigus and bullous impetigo. Curr Opin Cell Biol 2004, 16:536-543
11. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR: Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999, 103:461-468
12. Amagai M, Koch PJ, Nishikawa T, Stanley JR: Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol 1996, 106:351-355 (Pubitemid 26094622)
13. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR: Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 2000, 6:1275-1277
14. Hanakawa Y, Schechter NM, Lin C, Nishifuji K, Amagai M, Stanley JR: Enzymatic and molecular characteristics of the efficiency and specificity of exfoliative toxin cleavage of desmoglein 1. J Biol Chem 2004, 279:5268-5277
15. Johnston GA: Treatment of bullous impetigo and the staphylococcal scalded skin syndrome in infants. Expert Rev Anti Infect Ther 2004, 2:439-446
16. Ladhani S: Recent developments in staphylococcal scalded skin syndrome. Clin Microbiol Infect 2001, 7:301-307 (Pubitemid 34966126)
17. Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM: Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 1999, 12:224-242
18. Kemler R, Ozawa M, Ringwald M: Calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 1989, 1:892-897
19. Hanakawa Y, Selwood T, Woo D, Lin C, Schechter NM, Stanley JR: Calcium-dependent conformation of desmoglein 1 is required for its cleavage by exfoliative toxin. J Invest Dermatol 2003, 121:383-389
20. Amagai M, Ishii K, Hashimoto T, Gamou S, Shimizu N, Nishikawa T: Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol 1995, 105:243-247
21. Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL: Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005, 115:888-899 (Pubitemid 40489393)
22. Yokouchi M, Saleh MA, Kuroda K, Hachiya T, Stanley JR, Amagai M, Ishii K: Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol 2009, 129:2156-2166
23. Wheeler GN, Parker AE, Thomas CL, Ataliotis P, Poynter D, Arnemann J, Rutman AJ, Pidsley SC, Watt FM, Rees DA, Buxton RS, Magee AI: Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules. Proc Natl Acad Sci USA 1991, 88:4796-4800
24. Andl CD, Stanley JR: Central role of the plakoglobin-binding domain for desmoglein 3 incorporation into desmosomes. J Invest Dermatol 2001, 117:1068-1074
25. Marcozzi C, Burdett IDJ, Buxton RS, Magee AI: Coexpression of both types of desmosomal cadherin and plakoglobin confers strong intercellular adhesion. J Cell Sci 1998, 111:495-509
26. Getsios S, Amargo EV, Dusek RL, Ishii K, Sheu L, Godsel LM, Green KJ: Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion. Differentiation 2004, 72:419-433 (Pubitemid 41702119)
27. Chitaev NA, Leube RE, Troyanovsky RB, Eshkind LG, Franke WW, Troyanovsky SM: The binding of plakoglobin to desmosomal cadherins: patterns of binding sites and topogenic potential. J Cell Biol 1996, 133:359-369
28. Chitaev NA, Averbakh AZ, Troyanovsky RB, Troyanovsky SM: Molecular organization of the desmoglein-plakoglobin complex. J Cell Sci 1998, 111:1941-1949
29. Getsios S, Simpson CL, Kojima S, Harmon R, Sheu LJ, Dusek RL, Cornwell M, Green KJ: Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 2009, 185:1243-1258
30. Troyanovsky SM, Troyanovsky RB, Eshkind LG, Krutovskikh VA, Leube RE, Franke WW: Identification of the plakoglobin-binding domain in desmoglein and its role in plaque assembly and intermediate filament anchorage. J Cell Biol 1994, 127:151-160
31. Troyanovsky SM, Troyanovsky RB, Eshkind LG, Leube RE, Franke WW: Identification of amino acid sequence motifs in desmocollin, a desmosomal glycoprotein, that are required for plakoglobin binding and plaque formation. Proc Natl Acad Sci USA 1994, 91:10790-10794
32. Roh J-Y, Stanley JR: Plakoglobin binding by human Dsg3 (pemphigus vulgaris antigen) in keratinocytes requires the cadherin-like intracytoplasmic segment. J Invest Derm 1995, 104:720-724
33. Kowalczyk AP, Bornslaeger EA, Borgwardt JE, Palka HL, Dhaliwal AS, Corcoran CM, Denning MF, Green KJ: The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J Cell Biol 1997, 139:773-784
34. Pasdar M, Li Z, Chlumecky V: Plakoglobin: kinetics of synthesis, phosphorylation, stability, and interactions with desmoglein and Ecadherin. Cell Motil Cytoskeleton 1995, 258-272
35. Yin T, Getsios S, Caldelari R, Godsel LM, Kowalczyk AP, Muller EJ, Green KJ: Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and regulation by epidermal growth factor receptor. J Biol Chem 2005, 280:40355-40363
36. Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP: Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 2006, 281:7623-7634
37. Caldelari R, de Bruin A, Baumann D, Suter MM, Bierkamp C, Balmer V, Muller E: A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 2001, 153:823-834 (Pubitemid 34286113)
38. Shim JS, Kim DH, Kwon HJ: Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. Oncogene 2004, 23:1704-1711
39. Canes D, Chiang GJ, Billmeyer BR, Austin CA, Kosakowski M, Rieger-Christ KM, Libertino JA, Summerhayes IC: Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo. Int J Cancer 2005, 113:841-848
40. Rieger-Christ KM, Ng L, Hanley RS, Durrani O, Ma H, Yee AS, Libertino JA, Summerhayes IC: Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br J Cancer 2005, 92:2153-2159
41. Denning MF, Wang Y, Tibudan S, Alkan S, Nickoloff BJ, Qin JZ: Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ 2002, 9:40-52 (Pubitemid 34071992)
42. Kinsella TM, Nolan GP: Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996, 7:1405-1413
43. Dusek RL, Getsios S, Chen F, Park JK, Amargo EV, Cryns VL, Green KJ: The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem 2006, 281:3614-3624
44. Angst BD, Nilles LA, Green KJ: Desmoplakin II expression is not restricted to stratified epithelia. J Cell Sci 1990, 97:247-257
45. Halbert C, Demers G, Galloway D: The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol 1992, 66:2125-2134
46. Meyers C, Laimins LA: In vitro systems for the study and propagation of human papillomaviruses. Curr Top Microbiol Immunol 1994, 186:199-215
47. Huen AC, Park JK, Godsel LM, Chen X, Bannon LJ, Amargo EV, Hudson TY, Mongiu AK, Leigh IM, Kelsell DP, Gumbiner BM, Green KJ: Intermediate filament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. J Cell Biol 2002, 159:1005-1017
48. Simpson CL, Kojima S, Getsios S: RNA interference in keratinocytes and an organotypic model of human epidermis, Methods Mol Biol 585:127-146
49. Meyers C, Frattini MG, Hudson JB, Laimins LA: Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992, 257:971-973
50. Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, Chen X, Wahl JK, 3rd, Denning MF, Green KJ: Plakophilin 2: a critical scaffold for PKCα that regulates intercellular junction assembly. J Cell Biol 2008, 181:605-613 (Pubitemid 351717508)
51. LaFlamme SE, Thomas LA, Yamada SS, Yamada KM: Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in receptor localization, cell spreading and migration, and matrix assembly. J Cell Biol 1994, 126:1287-1298
52. Norvell SM, Green KJ: Contributions of extracellular and intracellular domains of full length and chimeric cadherin molecules to junction assembly in epithelial cells. J Cell Sci 1998, 111:1305-1318
53. Serpente N, Marcozzi C, Roberts GA, Bao Q, Angst BD, Hirst EMA, Burdett IDJ, Buxton RS, Magee AI: Extracellularly truncated desmoglein 1 compromises desmosomes in MDCK cells. Mol Membr Biol 2000, 17:175-183
54. Troyanovsky SM, Eshkind LG, Troyanovsky RB, Leube RE, Franke WW: Contributions of cytoplasmic domains of desmosomal cadherins to desmosome assembly and intermediate filament anchorage. Cell 1993, 72:561-574
55. Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, Cool C, Heasley LE: γ-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 2002, 21:7497-7506
56. Hanakawa Y, Amagai M, Shirakata Y, Yahata Y, Tokumaru S, Yamasaki K, Tohyama M, Sayama K, Hashimoto K: Differential effects of desmoglein 1 and desmoglein 3 on desmosome formation. J Invest Dermatol 2002, 119:1231-1236
57. Allen E, Yu Q-C, Fuchs E: Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 1996, 133:1367-1382 (Pubitemid 26192336)
58. Ishii K, Norvell SM, Bannon LJ, Amargo EV, Pascoe LT, Green KJ: Assembly of desmosomal cadherins into desmosomes is isoform dependent. J Invest Dermatol 2001, 117:26-35
59. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001, 114:111-118
60. Runswick SK, O'Hare MJ, Jones L, Streuli CH, Garrod DR: Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 2001, 3:823-830 (Pubitemid 32842688)
61. Tselepis C, Chidgey M, North A, Garrod D: Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci USA 1998, 95: 8064-8069
62. Klessner JL, Desai BV, Amargo EV, Getsios S, Green KJ: EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol Biol Cell 2009, 20:328-337
63. Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, Stack MS, Green KJ: Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 2004, 279:37191-37200
64. Nishifuji K, Sugai M, Amagai M: Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci 2008, 49:21-31
65. Steeves EB, Chelack BJ, Clark EG, Haines DM: Altered immunohistochemical staining for desmoglein in skin biopsies in canine pemphigus foliaceus. J Vet Diagn Invest 2002, 14:53-56
66. Kopp T, Sitaru C, Pieczkowski F, Schneeberger A, Fodinger D, Zillikens D, Stingl G, Karlhofer FM: IgA pemphigus - occurrence of antidesmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient. J Dtsch Dermatol Ges 2006, 4:1045-1050
67. Ishii K, Lin C, Siegel DL, Stanley JR: Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies. J Invest Dermatol 2008, 128:939-948 (Pubitemid 351374311)
68. Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T, Koyasu S, Nishikawa T, Amagai M: Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003, 170:2170-2178
69. Hashimoto T, Kiyokawa C, Mori O, Miyasato M, Chidgey MAJ, Garrod DR, Kobayashi Y, Komori K, Ishii K, Amagai M, Nishikawa T: Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 1997, 109: 127-131
70. Muller R, Heber B, Hashimoto T, Messer G, Mullegger R, Niedermeier A, Hertl M: Autoantibodies against desmocollins in European patients with pemphigus. Clin Exp Dermatol 2009, 34:898-903
71. Waschke J: The desmosome and pemphigus. Histochem Cell Biol 2008, 130:21-54
72. Kitajima Y, Aoyama Y: A perspective of pemphigus from bedside and laboratory-bench. Clin Rev Allergy Immunol 2007, 33:57-66
73. Heupel WM, Zillikens D, Drenckhahn D, Waschke J: Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J Immunol 2008, 181:1825-1834
74. Waschke J, Bruggeman P, Baumgartner W, Zillikens D, Drenckhahn D: Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest 2005, 115:3157-3165
75. Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H, Bolli R, Hunziker T, Suter MM, Muller EJ: Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J 2006, 25:3298-3309 (Pubitemid 44141788)
76. Aoyama Y, Kitajima Y: Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line. DJM-1 cells. J Invest Dermatol 1999, 112:67-71 (Pubitemid 29024708)
77. Kitajima Y: Mechanisms of desmosome assembly and disassembly. Clin Exp Dermatol 2002, 27:684-690
78. Patel GK: Treatment of staphylococcal scalded skin syndrome. Expert Rev Anti Infect Ther 2004, 2:575-587
79. Murray RJ: Recognition and management of Staphylococcus aureus toxin-mediated disease. Intern Med J 2005, 35(Suppl 2):S106-S119
80. Ito Y, Funabashi Yoh M, Toda K, Shimazaki M, Nakamura T, Morita E: Staphylococcal scalded-skin syndrome in an adult due to methicillin-resistant Staphylococcus aureus. J Infect Chemother 2002, 8:256-261
81. Acland KM, Darvay A, Griffin C, Aali SA, Russell-Jones R: Staphylococcal scalded skin syndrome in an adult associated with methicillin-resistant Staphylococcus aureus. Br J Dermatol 1999, 140:518-520 (Pubitemid 29182889)
82. Yamaguchi T, Yokota Y, Terajima J, Hayashi T, Aepfelbacher M, Ohara M, Komatsuzawa H, Watanabe H, Sugai M: Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis 2002, 185:1511-1516
83. Brennan D, Hu Y, Medhat W, Dowling A, Mahoney MG: Superficial dsg2 expression limits epidermal blister formation mediated by pemphigus foliaceus antibodies and exfoliative toxins, Dermatol Res Pract 2010, 2010:410278
84. Marks PA, Xu WS: Histone deacetylase inhibitors: potential in cancer therapy. J Cell Biochem 2009, 107:600-608
85. Ma X, Ezzeldin HH, Diasio RB: Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 2009, 69:1911-1934
86. Lee MJ, Kim YS, Kummar S, Giaccone G, Trepel JB: Histone deacetylase inhibitors in cancer therapy. Curr Opin Oncol 2008, 20:639-649